We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Things to consider when buying and using products.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Attributions of risk and blame in smart product failure.
The government is committed to ensuring that the system for testing construction products is effective and inspires public and market confidence.
How a marketing authorisation holder should report a defect with a veterinary medicine.
How to use a before-and-after study to evaluate your digital health product.
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
Information about the Working Group on Product Recalls and Safety.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How to use a quasi-experimental study to evaluate your digital health product.
Information on OPSS product safety alerts, reports and recalls for unsafe products and resources for consumers, businesses and regulators.
How to use a cost benefit analysis to evaluate your digital health product.
The rules about product labelling - including special rules for retailers and manufacturers in different business sectors (like food, jewellery and toys)
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How the MHRA makes decisions on what is a medicinal product (borderline products).
What you need to know about and do to comply with the law and keep consumers safe.
We are inviting views on the long-term approach to product safety and how to ensure that the regulatory framework is fit for the future.
Product security factsheet accompanying the Product Security and Telecommunications Infrastructure Bill, outlining the problems the Bill will address and how.
Documents relating to the independent review led by Paul Morrell OBE and Anneliese Day KC.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.